Marder K - Search Results

1

The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson disease.

Gan-Or Z, Amshalom I, Bar-Shira A, Gana-Weisz M, Mirelman A, Marder K, Bressman S, Giladi N, Orr-Urtreger A. Gan-Or Z, et al. Among authors: marder k. J Neurol. 2015 Nov;262(11):2443-7. doi: 10.1007/s00415-015-7868-3. Epub 2015 Aug 2. J Neurol. 2015. PMID: 26233692

2

Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease.

Sano M, Bell K, Cote L, Dooneief G, Lawton A, Legler L, Marder K, Naini A, Stern Y, Mayeux R. Sano M, et al. Among authors: marder k. Arch Neurol. 1992 Nov;49(11):1137-41. doi: 10.1001/archneur.1992.00530350051019. Arch Neurol. 1992. PMID: 1444880 Clinical Trial.

3

An estimate of the incidence of depression in idiopathic Parkinson's disease.

Dooneief G, Mirabello E, Bell K, Marder K, Stern Y, Mayeux R. Dooneief G, et al. Among authors: marder k. Arch Neurol. 1992 Mar;49(3):305-7. doi: 10.1001/archneur.1992.00530270125028. Arch Neurol. 1992. PMID: 1536634

4

A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender.

Mayeux R, Denaro J, Hemenegildo N, Marder K, Tang MX, Cote LJ, Stern Y. Mayeux R, et al. Among authors: marder k. Arch Neurol. 1992 May;49(5):492-7. doi: 10.1001/archneur.1992.00530290076015. Arch Neurol. 1992. PMID: 1580811

5

Tritiated imipramine binding. A peripheral marker for serotonin in Parkinson's disease.

Sano M, Stanley M, Lawton A, Coté L, Williams J, Stern Y, Marder K, Mayeux R. Sano M, et al. Among authors: marder k. Arch Neurol. 1991 Oct;48(10):1052-4. doi: 10.1001/archneur.1991.00530220072022. Arch Neurol. 1991. PMID: 1718247

6

Are demented patients with Parkinson's disease accurately reflected in prevalence surveys? A survival analysis.

Marder K, Leung D, Tang M, Bell K, Dooneief G, Cote L, Stern Y, Mayeux R. Marder K, et al. Neurology. 1991 Aug;41(8):1240-3. doi: 10.1212/wnl.41.8.1240. Neurology. 1991. PMID: 1866013

7

An estimate of the incidence of dementia in idiopathic Parkinson's disease.

Mayeux R, Chen J, Mirabello E, Marder K, Bell K, Dooneief G, Cote L, Stern Y. Mayeux R, et al. Among authors: marder k. Neurology. 1990 Oct;40(10):1513-7. doi: 10.1212/wnl.40.10.1513. Neurology. 1990. PMID: 2215941

8

An estimate of the prevalence of dementia in idiopathic Parkinson's disease.

Mayeux R, Stern Y, Rosenstein R, Marder K, Hauser A, Cote L, Fahn S. Mayeux R, et al. Among authors: marder k. Arch Neurol. 1988 Mar;45(3):260-2. doi: 10.1001/archneur.1988.00520270034017. Arch Neurol. 1988. PMID: 3341950

9

A standardized technique for establishing onset and duration of symptoms of Alzheimer's disease.

Sano M, Devanand DP, Richards M, Miller LW, Marder K, Bell K, Dooneief G, Bylsma FW, Lafleche G, Albert M, et al. Sano M, et al. Among authors: marder k. Arch Neurol. 1995 Oct;52(10):961-6. doi: 10.1001/archneur.1995.00540340045012. Arch Neurol. 1995. PMID: 7575223

10

The frequency and associated risk factors for dementia in patients with Parkinson's disease.

Marder K, Tang MX, Cote L, Stern Y, Mayeux R. Marder K, et al. Arch Neurol. 1995 Jul;52(7):695-701. doi: 10.1001/archneur.1995.00540310069018. Arch Neurol. 1995. PMID: 7619026

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

503 results

Search Page

Filters